What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
Open accessAbstract
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 1 million deaths in the first 6 months of the pandemic and huge economic and social upheaval internationally. An efficacious vaccine is essential to prevent further morbidity and mortality. Although some countries might deploy COVID-19 vaccines on the strength of safety and immunogenicity data alone, the goal of vaccine development is to gain direct evidence of vaccine efficacy in protecting humans against SARS-CoV-2 infection and COVID-19 so that manufacture of efficacious vaccines can be selectively upscaled. A candidate vaccine against SARS-CoV-2 might act against infection, disease, or transmission, and a vaccine capable of reducing any of these elements could contribute to disease control. However, the most important efficacy endpoint, protection against severe disease and death, is difficult to assess in phase 3 clinical trials. In this Review, we explore the challenges in assessing the efficacy of candidate SARS-CoV-2 vaccines, discuss the caveats needed to interpret reported efficacy endpoints, and provide insight into answering the seemingly simple question, "Does this COVID-19 vaccine work?"
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The long-term risks and benefits of a SARS-CoV-2 vaccine will take a long time to fully evaluate in adults.
“the long-term risks and benefits of a SARS-CoV-2 vaccine will take a long time to fully evaluate in adults33 while the public health needs of a vaccine are pressing.”
From SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges (2021) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048 · see citing works
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661 · see citing works
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,242 · see citing works
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660 · see citing works
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481 · see citing works
To, K. K., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C., Cai, J., Chan, J. M., Chik, T. S., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,045 · see citing works
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · see citing works
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607 · see citing works
Prevalence of Asymptomatic SARS-CoV-2 Infection
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,280 · see citing works
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · see citing works
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
Arons, M. M., Hatfield, K. M., Reddy, S. C., Kimball, A. A., James, A. E., Jacobs, J. R., Taylor, J., Spicer, K. B., Bardossy, A. C., Oakley, L. P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008457 · Cited by 2,051 · see citing works
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960 · see citing works
The COVID-19 vaccine development landscape
Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M. K., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,959 · see citing works
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Vesikari, T., Matson, D. O., Dennehy, P. H., Damme, P. V., Santosham, M., Rodriguez, Z. M., Dallas, M. J., Heyse, J. F., Goveia, M. G., BLACK, S. B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052664 · Cited by 1,871 · see citing works
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745 · see citing works
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works
Zheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., Xie, G., Lin, S., Wang, R., Yang, X., et al. (2020) · BMJ · doi:10.1136/bmj.m1443 · Cited by 1,439 · see citing works
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419 · see citing works
Restrepo, A. M. H., Camacho, A., Longini, I. M., Watson, C., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I. D., Doumbia, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32621-6 · Cited by 1,112 · see citing works
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Yu, J., Tostanoski, L. H., Peter, L., Mercado, N. B., McMahan, K., Mahrokhian, S. H., Nkolola, J. P., Liu, J., Li, Z., Chandrashekar, A., et al. (2020) · Science · doi:10.1126/science.abc6284 · Cited by 997 · see citing works
(2013) · Pluto Press eBooks · doi:10.2307/j.ctt183pb3w.5 · Cited by 908 · see citing works
Vaccines for preventing influenza in healthy adults
Jefferson, T., Pietrantonj, C. D., Rivetti, A., Bawazeer, G. A., Al‐Ansary, L. A., & Ferroni, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub4 · Cited by 898 · see citing works
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816 · see citing works
Scola, B. L., Bideau, M. L., Andréani, J., Hoang, V. T., Grimaldier, C., Colson, P., Gautret, P., & Raoult, D. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03913-9 · Cited by 812 · see citing works
Interpreting a covid-19 test result
Watson, J., Whiting, P. F., & Brush, J. E. (2020) · BMJ · doi:10.1136/bmj.m1808 · Cited by 712 · see citing works
Vaccines for preventing influenza in the elderly
Demicheli, V., Jefferson, T., Pietrantonj, C. D., Ferroni, E., Thorning, S., Thomas, R. E., & Rivetti, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004876.pub4 · Cited by 706 · see citing works
Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis
Zhu, J., Ji, P., Pang, J., Zhong, Z., Li, H., He, C., Zhang, J., & Zhao, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25884 · Cited by 622 · see citing works
Geographic and Genomic Distribution of SARS-CoV-2 Mutations
Mercatelli, D., & Giorgi, F. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01800 · Cited by 589 · see citing works
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19
van Kasteren, P. B., van der Veer, B., van den Brink, S., Wijsman, L. A., de Jonge, J., van den Brandt, A., Molenkamp, R., Reusken, C. B. E. M., & Meijer, A. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104412 · Cited by 470 · see citing works
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Whitman, J. D., Hiatt, J. B., Mowery, C. T., Shy, B. R., Yu, R., Yamamoto, T. N., Rathore, U., Goldgof, G. M., Whitty, C., Woo, J. M., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0659-0 · Cited by 451 · see citing works
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Younes, N., Al‐Sadeq, D. W., Al-Jighefee, H. T., Younes, S. N., Al-Jamal, O., Daas, H. I., Yassine, H. M., & Nasrallah, G. K. (2020) · Viruses · doi:10.3390/v12060582 · Cited by 437 · see citing works
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infectionPreprint
Seow, J., Graham, C., Merrick, B., Acors, S., Steel, K., Hemmings, O., O'Bryne, A., Kouphou, N., Pickering, S., Rui, G.-L. P., et al. (2020) · medRxiv · doi:10.1101/2020.07.09.20148429 · Cited by 411 · see citing works
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Soares‐Weiser, K., MacLehose, H. G., Bergman, H., Ben‐Aharon, I., Nagpal, S., Goldberg, E., Pitan, F., & Cunliffe, N. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008521.pub3 · Cited by 389 · see citing works
Alexandersen, S., Chamings, A., & Bhatta, T. R. (2020) · Nature Communications · doi:10.1038/s41467-020-19883-7 · Cited by 305 · see citing works
Rotavirus vaccines. WHO position paper – January 2013.
Editorial, A. (2013) · PubMed · Cited by 295 · see citing works
Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
Eyal, N., Lipsitch, M., & Smith, P. G. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa152 · Cited by 283 · see citing works
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Preprint
Sekine, T., Perez‐Potti, A., Rivera‐Ballesteros, O., Strålin, K., Gorin, J., Olsson, A., Llewellyn‐Lacey, S., Kamal, H., Bogdanović, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272 · see citing works
Improving recruitment of older people to research through good practice
McMurdo, M. E. T., Roberts, H. C., Parker, S. G., Wyatt, N., May, H. M., Goodman, C. M., Jackson, S., Gladman, J. R. F., O’Mahony, S., Ali, K., et al. (2011) · Age and Ageing · doi:10.1093/ageing/afr115 · Cited by 267 · see citing works
Test performance evaluation of SARS-CoV-2 serological assaysPreprint
Whitman, J. D., Hiatt, J. B., Mowery, C. T., et al. (2020) · medRxiv · doi:10.1101/2020.04.25.20074856 · Cited by 252 · see citing works
Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap
Weinberg, G. A., & Szilagyi, P. G. (2010) · The Journal of Infectious Diseases · doi:10.1086/652404 · Cited by 230 · see citing works
Vaccines for preventing influenza in healthy adults
Demicheli, V., Jefferson, T., Ferroni, E., Rivetti, A., & Pietrantonj, C. D. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub6 · Cited by 228 · see citing works
Vaccines for preventing influenza in the elderly
Rivetti, D., Jefferson, T., Thomas, R. E., Rudin, M., Rivetti, A., Pietrantonj, C. D., & Demicheli, V. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004876.pub2 · Cited by 206 · see citing works
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 199 · see citing works
Zhu, L., Gong, N., Liu, B., Xia, L., Chen, D., Chen, S., Shu, H., Ma, K., Xu, X., Guo, Z., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.03.039 · Cited by 193 · see citing works
Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
D'Cruz, R. J., Currier, A. W., & Sampson, V. B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00468 · Cited by 151 · see citing works
Vaccine effects and impact of vaccination programmes in post-licensure studies
Hanquet, G., Valenciano, M., Simondon, F., & Moren, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.006 · Cited by 144 · see citing works
Wagner, A., & Weinberger, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00717 · Cited by 123 · see citing works
Lambert, P.-H., Ambrosino, D. M., Andersen, S. R., Baric, R. S., Black, S. B., Chen, R. T., Dekker, C. L., Didierlaurent, A. M., Graham, B. S., Martin, S. D., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.05.064 · Cited by 119 · see citing works
Self-citationHepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Ho, J. K., Jeevan-Raj, B. P., & Netter, H. J. (2020) · Viruses · doi:10.3390/v12020126 · Cited by 105 · see citing works
Statistical methodologies to pool across multiple intervention studies
Bangdiwala, S. I., Bhargava, A., O’Connor, D. P., Robinson, T. N., Michie, S., Murray, D. M., Stevens, J., Belle, S. H., Templin, T., & PRATT, C. A. (2016) · Translational Behavioral Medicine · doi:10.1007/s13142-016-0386-8 · Cited by 100 · see citing works
The search for a COVID-19 animal model
Lakdawala, S. S., & Menachery, V. D. (2020) · Science · doi:10.1126/science.abc6141 · Cited by 97 · see citing works
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Soares‐Weiser, K., MacLehose, H. G., Bergman, H., Ben‐Aharon, I., Nagpal, S., Goldberg, E., Pitan, F., & Cunliffe, N. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008521.pub2 · Cited by 90 · see citing works
Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data
Basta, N. E., Halloran, M. E., Matrajt, L., & Longini, I. M. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn259 · Cited by 87 · see citing works
Pooling Data From Individual Clinical Trials in the COVID-19 Era
Petkova, E., Antman, E. M., & Troxel, A. B. (2020) · JAMA · doi:10.1001/jama.2020.13042 · Cited by 83 · see citing works
Recruitment and Retention of Elderly Patients in Clinical Trials: Issues and Strategies
Cassidy, E. L., Baird, E., & Sheikh, J. I. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200105000-00005 · Cited by 82 · see citing works
Velázquez, F. R., Linhares, A. C., Muñoz, S., Pamela Serón, S., Lorca, P., DeAntonio, R., & Ortega‐Barría, E. (2017) · BMC Pediatrics · doi:10.1186/s12887-016-0771-y · Cited by 73 · see citing works
Restricted Social Engagement among Adults Living with Chronic Conditions
Meek, K., Bergeron, C. D., Towne, S. D., Ahn, S., Ory, M. G., & Smith, M. L. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010158 · Cited by 64 · see citing works
Transmission of SARS-CoV-2, Required Developments in Research and Associated Public Health Concerns
Khan, S., Liu, J., & Xue, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00310 · Cited by 61 · see citing works
Vekemans, J., Crofts, J., Baker, C. J., Goldblatt, D., Heath, P. T., Madhi, S. A., Doaré, K. L., Andrews, N. J., Pollard, A. J., Saha, S. K., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.039 · Cited by 58 · see citing works
Self-citationColonisation endpoints in Streptococcus pneumoniae vaccine trials
Auranen, K. J., Rinta‐Kokko, H., Goldblatt, D., Nohynek, H., O’Brien, K. L., Satzke, C., Simell, B., Tanskanen, A. J., & Käyhty, H. M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.061 · Cited by 57 · see citing works
Antibody testing will enhance the power and accuracy of COVID-19-prevention trials
Lipsitch, M., Kahn, R. J., & Mina, M. J. (2020) · Nature Medicine · doi:10.1038/s41591-020-0887-3 · Cited by 57 · see citing works
Herd immunity and vaccination of children for COVID-19
Velavan, T. P., Pollard, A. J., & Kremsner, P. G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.065 · Cited by 56 · see citing works
Self-citationSensitivity, Specificity, and Vaccine Efficacy
Lachenbruch, P. A. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00042-7 · Cited by 50 · see citing works
Bar‐Zeev, N., King, C., Phiri, T., Beard, J., Mvula, H., Crampin, A. C., Heinsbroek, E., Lewycka, S. O., Tate, J. E., Parashar, U. D., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30314-0 · Cited by 50 · see citing works
Medical Management of COVID-19: Evidence and Experience
Bose, S., Adapa, S., Aeddula, N. R., Roy, S., Nandikanti, D. K., Vupadhyayula, P. M., Naramala, S., Gayam, V. B. R., Muppidi, V., & Konala, V. M. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4201 · Cited by 45 · see citing works
Allsup, S. J., & Gosney, M. (2002) · Gerontology · doi:10.1159/000052837 · Cited by 36 · see citing works
Human challenge models: tools to accelerate the development of malaria vaccines
Cooper, M. M., Loiseau, C., McCarthy, J., & Doolan, D. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1580577 · Cited by 28 · see citing works
Using simulation to aid trial design: Ring-vaccination trials
Hitchings, M. D. T., Grais, R. F., & Lipsitch, M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005470 · Cited by 28 · see citing works
Baay, M. F. D., & Neels, P. (2020) · Biologicals · doi:10.1016/j.biologicals.2020.08.006 · Cited by 26 · see citing works
Willingness to Participate in Vaccine-Related Clinical Trials among Older Adults
Raheja, D., Davila, E. P., Johnson, E. T., Deović, R., McCullough, M. P., & Rouphael, N. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081743 · Cited by 25 · see citing works
Meiring, J., Giubilini, A., Savulescu, J., Pitzer, V. E., & Pollard, A. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz630 · Cited by 18 · see citing works
Self-citationVaccines for preventing influenza in the elderly
- (2018) · Kazan medical journal · doi:10.17816/kmj8918 · Cited by 10 · see citing works
Flagged first, then by citations
6 of the 79 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [71]Yu J Tostanoski LH Peter L DNA vaccine protection against SARS-CoV-2 in rhesus macaques Science 369 2020 806 811 32434945 PMC7243363
Cited by
Sorted by citations
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101544 · Cited by 2,397 · see citing works
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Scully, M., Singh, D. N., Lown, R. N., Poles, A., Solomon, T., Levi, M. M., Goldblatt, D., Kotouček, P., Thomas, W. D., & Lester, W. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105385 · Cited by 964 · see citing works
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Chemaitelly, H., Tang, P., Hasan, M. R., AlMukdad, S., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Coyle, P., Ayoub, H. H., Al Kanaani, Z., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114114 · Cited by 831 · see citing works
Schwarzinger, M., Watson, V., Arwidson, P., Alla, F., & Luchini, S. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00012-8 · Cited by 765 · see citing works
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Zhang, J., Dong, X., Liu, G., & Gao, Y. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 733 · see citing works
Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. (2021) · Vaccines · doi:10.3390/vaccines9010042 · Cited by 675 · see citing works
Mohammed, I., Nauman, A., Paul, P., Ganesan, S., Chen, K.-H., Jalil, S. M. S., Jaouni, S. H., Kawas, H., Khan, W. A., Vattoth, A. L., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2027160 · Cited by 406 · see citing works
Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Zanza, C., Romenskaya, T., Manetti, A. C., Franceschi, F., Russa, R. L., Bertozzi, G., Maiese, A., Savioli, G., Volonnino, G., & Longhitano, Y. (2022) · Medicina · doi:10.3390/medicina58020144 · Cited by 395 · see citing works
Heinz, F. X., & Stiasny, K. (2021) · npj Vaccines · doi:10.1038/s41541-021-00369-6 · Cited by 362 · see citing works
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Li, Y., Tenchov, R., Smoot, J., Liu, C., Watkins, S., & Zhou, Q. A. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00120 · Cited by 345 · see citing works
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Bettini, E., & Locci, M. (2021) · Vaccines · doi:10.3390/vaccines9020147 · Cited by 283 · see citing works
Wang, K., Wong, E. L., Ho, K., Cheung, A. W.-L., Yau, P. S.-Y., Dong, D., Wong, S. Y. S., & Yeoh, E. (2021) · Vaccines · doi:10.3390/vaccines9010062 · Cited by 270 · see citing works
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Cordina, M., Lauri, M. A., & Lauri, J. (2021) · Pharmacy Practice · doi:10.18549/pharmpract.2021.1.2317 · Cited by 261 · see citing works
Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals
Alam, S. T., Ahmed, S., Ali, S. M., Sarker, S., Kabir, G., & ul-Islam, A. (2021) · International Journal of Production Economics · doi:10.1016/j.ijpe.2021.108193 · Cited by 248 · see citing works
Jentsch, P. C., Anand, M., & Bauch, C. T. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00057-8 · Cited by 226 · see citing works
Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients
Azzi, L., Gasperina, D. D., Veronesi, G., Shallak, M., Ietto, G., Iovino, D., Baj, A., Gianfagna, F., Maurino, V., Focosi, D., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103788 · Cited by 220 · see citing works
Wu, Y., Cheng, X., Jiang, G., Tang, H., Ming, S., Tang, L., Lu, J., Guo, C., Shan, H., & Huang, X. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00232-5 · Cited by 200 · see citing works
COVID-19 vaccination: The road ahead
Altmann, D. M., & Boyton, R. J. (2022) · Science · doi:10.1126/science.abn1755 · Cited by 195 · see citing works
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Heidary, M., Kaviar, V. H., Shirani, M., Ghanavati, R., Motahar, M., Sholeh, M., Ghahramanpour, H., & Khoshnood, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.927306 · Cited by 172 · see citing works
Kheraldine, H., Rachid, O., Habib, A. M., Moustafa, A. A., Benter, I. F., & Akhtar, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113908 · Cited by 152 · see citing works
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Mohamed, K., Rzymski, P., Islam, M. S., Makuku, R., Mushtaq, A., Khan, A., Ivanovska, M., Makka, S. A., Hashem, F., Marquez, L. P., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27487 · Cited by 145 · see citing works
Kang, M., Xin, H., Yuan, J., Ali, S. T., Liang, Z., Zhang, J., Hu, T., Lau, E. H. Y., Zhang, Y., Zhang, M., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.10.2100815 · Cited by 139 · see citing works
Efforts at COVID-19 Vaccine Development: Challenges and Successes
Haque, A., & Pant, A. B. (2020) · Vaccines · doi:10.3390/vaccines8040739 · Cited by 139 · see citing works
Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., Ji, R., Lin, M., Zhu, Z., Türeci, Ö., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01330-9 · Cited by 133 · see citing works
Higdon, M. M., Wahl, B., Jones, C. B., Rosen, J. G., Truelove, S., Baidya, A., Nande, A., ShamaeiZadeh, P. A., Walter, K. K., Feikin, D. R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac138 · Cited by 125 · see citing works
SARS‐CoV‐2 variants and vulnerability at the global level
Chavda, V. P., Patel, A., & Vaghasiya, D. D. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27717 · Cited by 132 · see citing works
Gorman, M. J., Patel, N., Guebre‐Xabier, M., Zhu, A. L., Atyeo, C. G., Pullen, K. M., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J.-H., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100405 · Cited by 121 · see citing works
Katikireddi, S. V., Cerqueira-Silva, T., Vasileiou, E., Robertson, C., Amele, S., Pan, J., Taylor, B., Boaventura, V., Werneck, G. L., Flores-Ortiz, R., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02754-9 · Cited by 124 · see citing works
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
He, Q., Mao, Q., Zhang, J., Bian, L., Gao, F., Wang, J., Xu, M., & Liang, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669339 · Cited by 108 · see citing works
Alfego, D., Sullivan, A., Poirier, B., Williams, J., Grover, A., Gillim, L., Adcock, D. M., & Letovsky, S. I. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100902 · Cited by 103 · see citing works
Brockman, M. A., Mwimanzi, F. M., Lapointe, H. R., Sang, Y., Agafitei, O., Cheung, P. K., Ennis, S., Ng, K., Basra, S., Lim, L. Y., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab592 · Cited by 104 · see citing works
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Lewnard, J. A., Patel, M. M., Jewell, N. P., Verani, J. R., Kobayashi, M., Tenforde, M. W., Dean, N. E., Cowling, B. J., & Lopman, B. A. (2021) · Epidemiology · doi:10.1097/ede.0000000000001366 · Cited by 103 · see citing works
Yang, Z., Fu, X., Ma, D., Wang, Y., Peng, L., Shi, J., Sun, J., Gan, X., Deng, Y., & Yang, W. (2021) · Small · doi:10.1002/smll.202103993 · Cited by 95 · see citing works
Hao, X., Peng, X., Ding, X., Qin, Y., Lv, M., Li, J., & Li, K. (2021) · Nurse Education Today · doi:10.1016/j.nedt.2021.105183 · Cited by 94 · see citing works
Tscherne, A., Schwarz, J. H., Rohde, C., Kupke, A., Kalodimou, G., Limpinsel, L., Okba, N. M. A., Bošnjak, B., Sandrock, I., Odak, I., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026207118 · Cited by 88 · see citing works
Kumar, M., Gulati, S., Ansari, A. H., Phutela, R., Acharya, S., Azhar, M., Murthy, J., Kathpalia, P., Kanakan, A., Maurya, R., et al. (2021) · eLife · doi:10.7554/elife.67130 · Cited by 87 · see citing works
Muena, N. A., García‐Salum, T., Pardo‐Roa, C., Avendaño, M. J., Serrano, E. F., Lévican, J., Almonacid, L. I., Valenzuela, G. H., Poblete, E., Strohmeier, S., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103972 · Cited by 85 · see citing works
Safety & effectiveness of COVID-19 vaccines
Chirico, F., da Silva, J. A. T., Tsigaris, P., & Sharun, K. (2022) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_474_21 · Cited by 84 · see citing works
Jin, P., Li, J., Pan, H., Wu, Y.-F., & Zhu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00481-y · Cited by 86 · see citing works
Liang, L.-L., Kuo, H., Ho, H. J., & Wu, C. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05019 · Cited by 77 · see citing works
Qudus, M. S., Tian, M., Sirajuddin, S., Liu, S., Afaq, U., Wali, M., Liu, J., Pan, P., Luo, Z., Zhang, Q., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28751 · Cited by 77 · see citing works
Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID‐A study
Ríos, S. S., Romero, M. M., Zamora, E. B. C., Sahuquillo, M. T. T., Rizos, L. R., Sánchez‐Jurado, P. M., Nievas, G. S., Señalada, J. J. B., García-Nogueras, I., Cazalla, J. D. D. E., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17153 · Cited by 74 · see citing works
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Altawalah, H. (2021) · Vaccines · doi:10.3390/vaccines9080910 · Cited by 71 · see citing works
COVID-19 Vaccine: Critical Questions with Complicated Answers
Haidere, M. F., Ratan, Z. A., Nowroz, S., Zaman, S. B., Jung, Y.-J., Hosseinzadeh, H., & Cho, J. Y. (2020) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.178 · Cited by 71 · see citing works
Effective Demand Forecasting in Health Supply Chains: Emerging Trend, Enablers, and Blockers
Subramanian, L. (2021) · Logistics · doi:10.3390/logistics5010012 · Cited by 70 · see citing works
Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., Kim, M. S., Kim, J. Y., Koyanagi, A., Jacob, L., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab592 · Cited by 68 · see citing works
Khatatbeh, M. M., Albalas, S., Khatatbeh, H., Momani, W., Melhem, O., Omari, O. A., Tarhini, Z., A’aqoulah, A., Al‐Jubouri, M. B., Nashwan, A. J., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13798-2 · Cited by 65 · see citing works
SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines
Rogliani, P., Chetta, A. A., Cazzola, M., & Calzetta, L. (2021) · Vaccines · doi:10.3390/vaccines9030227 · Cited by 63 · see citing works
Duque, J. S. R., Wang, X., Leung, D., Cheng, S. M. S., Cohen, C. A., Mu, X., Hachim, A., Zhang, Y., Chan, S. M., Chaothai, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31485-z · Cited by 63 · see citing works
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Meschi, S., Matusali, G., Colavita, F., Lapa, D., Bordi, L., Puro, V., Leoni, B. D., Galli, C., Capobianchi, M. R., & Castilletti, C. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0700 · Cited by 63 · see citing works
Elalamy, I., Gerotziafas, G., Alamowitch, S., Laroche, J.-P., Dreden, P. V., Ageno, W., Beyer‐Westendorf, J., Cohen, A. T., Jiménez, D., Brenner, B., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1499-0119 · Cited by 61 · see citing works
Marra, A. R., Kobayashi, T., Suzuki, H., Alsuhaibani, M., Tofaneto, B. M., Bariani, L. M., Auler, M. D. A., Salinas, J. L., Edmond, M. B., Doll, M. E., et al. (2022) · Journal of Infection · doi:10.1016/j.jinf.2021.12.035 · Cited by 62 · see citing works
Morales‐Núñez, J. J., Muñóz-Valle, J. F., Meza-López, C., Wang, L., Machado-Sulbarán, A. C., Torres-Hernández, P. C., Bedolla‐Barajas, M., la O-Gómez, B. D., Balcázar-Félix, P., & Hernández‐Bello, J. (2021) · Vaccines · doi:10.3390/vaccines9070742 · Cited by 54 · see citing works
Rosano, G. M. C., Jankowska, E. A., Ray, R., Metra, M., Abdelhamid, M., Adamopoulos, S. N., Anker, S. D., Bayés‐Genís, A., Belenkov, Y. N., Gal, T. B., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2356 · Cited by 58 · see citing works
Jianqing, X., Ren, Z., Cao, K., Li, X., Yang, J., Luo, X., Zhu, L., Wang, X., Ding, L., Liang, J., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.789242 · Cited by 56 · see citing works
Cooper, D. M., Afghani, B., Byington, C. L., Cunningham, C. K., Golub, S., Lu, K. D., Radom-Aizik, S., Ross, L. F., Singh, J., Smoyer, W. E., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01402-z · Cited by 55 · see citing works
Kim, S. Y., & Yeniova, A. Ö. (2022) · Life Cycle · doi:10.54724/lc.2022.e10 · Cited by 55 · see citing works
Valckx, S., Crèvecoeur, J., Verelst, F., Vranckx, M., Hendrickx, G., Hens, N., Damme, P. V., Pepermans, K., Beutels, P., & Neyens, T. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.073 · Cited by 53 · see citing works
Göbel, C., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., Hamid, Q., Halwani, R., Temsah, M., Ziemann, M., et al. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00296-3 · Cited by 39 · see citing works
Ripp, T., & Röer, J. P. (2022) · BMC Psychology · doi:10.1186/s40359-022-00771-2 · Cited by 54 · see citing works
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
Bonfante, F., Costenaro, P., Cantarutti, A., Chiara, C. D., Bortolami, A., Petrara, M. R., Carmona, F., Pagliari, M., Cosma, C., Cozzani, S., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2021-052173 · Cited by 50 · see citing works
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways
Mekonnen, D. S., Mengist, H. M., & Jin, T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1991794 · Cited by 53 · see citing works
Deep learning-based detection of COVID-19 using wearables dataPreprint
Bogu, G. K., & Snyder, M. P. (2021) · medRxiv · doi:10.1101/2021.01.08.21249474 · Cited by 52 · see citing works
Lee, S. W., Moon, J., Lee, S.-K., Lee, H. J., Moon, S., Chung, S. J., Yeo, Y., Park, T. S., Park, D. W., Kim, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.779212 · Cited by 50 · see citing works
Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
Behera, P., Singh, A. K., Subba, S. H., Arjun, M. C., Sahu, D. P., Chandanshive, P. D., Pradhan, S. K., Parida, S. P., Mishra, A., Patro, B. K., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2034456 · Cited by 51 · see citing works
How Chinese Herbal Medicine Prevents Epidemics: From Ancient Pestilences to COVID-19 Pandemic
Wu, X., Zhang, W.-N., Hao, M., Liu, X., Xiao, J., Wang, T., Dong, Y.-Z., & Zhao, J. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2150049x · Cited by 51 · see citing works
Helfand, M., Fiordalisi, C. V., Wiedrick, J., Ramsey, K. L., Armstrong, C., Gean, E., Winchell, K., & Arkhipova-Jenkins, I. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4245 · Cited by 47 · see citing works
Pitzalis, M., Idda, M. L., Lodde, V., Loizedda, A., Lobina, M., Żołędziewska, M., Virdis, F., Delogu, G., Pirinu, F., Marini, M. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.781843 · Cited by 50 · see citing works
Insight into the role of clathrin‐mediated endocytosis inhibitors in SARS‐CoV‐2 infection
Alkafaas, S. S., Abdallah, A. M., Ghosh, S. B., Loutfy, S. A., Elkafas, S. S., Fattah, N. F. A., & Hessien, M. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2403 · Cited by 51 · see citing works
Abo, Y., Jamrozik, E., McCarthy, J. S., Roestenberg, M., Steer, A. C., & Osowicki, J. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00294-3 · Cited by 50 · see citing works
Wang, Y., Wang, X., Luu, L. D. W., Chen, S., Fu, J. X., Wang, S., Huang, X., Wang, L., Zhou, X., Chen, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848961 · Cited by 48 · see citing works
Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces
Kwok, H. F. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59170 · Cited by 46 · see citing works
Network models to evaluate vaccine strategies towards herd immunity in COVID-19
Tetteh, J. N. A., Nguyễn, V. K., & Hernandez-Vargas, E. A. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110894 · Cited by 51 · see citing works
COVID-19 Vaccination and The Eye
Wang, M. T. M., Niederer, R. L., McGhee, C. N. J., & Danesh-Meyer, H. V. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.02.011 · Cited by 48 · see citing works
Jacob, J. J., Vasudevan, K., Pragasam, A. K., Gunasekaran, K., Veeraraghavan, B., & Mutreja, A. (2021) · mBio · doi:10.1128/mbio.01188-21 · Cited by 47 · see citing works
The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations
Wiggins, K., Smith, M. A., & Schultz‐Cherry, S. (2021) · Viruses · doi:10.3390/v13061109 · Cited by 46 · see citing works
Fatima, M., Cheema, H. A., Khan, M. H. A., Shahid, H., Ali, M. S., Hassan, U., Murad, M. W., Rehman, M. A. U., & Farooq, H. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103486 · Cited by 46 · see citing works
Kantarcıoğlu, B., Iqbal, O., Walenga, J. M., Lewis, B., Lewis, J., Carter, C. A., Singh, M., Lievano, F. A., Tafur, A. J., Ramacciotti, E., et al. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211021498 · Cited by 44 · see citing works
Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro
Wang, R., Hu, Q., Wang, H., Zhu, G., Wang, M., Zhang, Q., Zhao, Y., Li, C., Zhang, Y., Ge, G., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.129 · Cited by 44 · see citing works
SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan, K. L., MacIntyre, C. R., McIntyre, P. B., & Nelson, M. R. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.07.016 · Cited by 42 · see citing works
COVID-19 Vaccination Efficacy and Safety Literature Review
Halim, M. (2021) · Journal of Immunology and Allergy · doi:10.37191/mapsci-2582-4333-3(1)-058 · Cited by 42 · see citing works
Si, R., Yao, Y., Zhang, X., Lu, Q., & Aziz, N. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.702699 · Cited by 43 · see citing works
Nath, R., Imtiaz, A., Nath, S. D., & Hasan, E. (2021) · Vaccines · doi:10.3390/vaccines9121405 · Cited by 42 · see citing works
Love, J., Keegan, L. T., Angulo, F. J., McLaughlin, J. M., Shea, K. M., Swerdlow, D. L., Samore, M. H., & Toth, D. J. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-97612-w · Cited by 40 · see citing works
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
McConnell, D. J., Hickey, C., Bargary, N., Trela-Larsen, L., Walsh, C., Barry, M. G., & Adams, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094640 · Cited by 42 · see citing works
Erawan, M. A. S. P., Zaid, Z., Pratondo, K., & Lestari, A. Y. (2021) · Al-sihah The Public Health Science Journal · doi:10.24252/al-sihah.v13i1.20647 · Cited by 41 · see citing works
Jiang, F., Liu, Y., Xue, Y., Cheng, P., Wang, J., Lian, J., & Gong, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109728 · Cited by 41 · see citing works
A Bibliometric Analysis of Publications on COVID-19 and Older Adults
Soytaş, R. B. (2021) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.21.0060 · Cited by 40 · see citing works
COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns
Sharun, K., Tiwari, R., Dhama, K., Rabaan, A. A., & Alhumaid, S. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1953350 · Cited by 42 · see citing works
Pannexin-1 channel opening is critical for COVID-19 pathogenesis
Luu, R. H., Valdebenito, S., Scemes, E., Cibelli, A., Spray, D. C., Rovegno, M., Tichauer, J. E., Cottignies-Calamarte, A., Rosenberg, A. R., Capron, C., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103478 · Cited by 39 · see citing works
The role of weather conditions in COVID-19 transmission: A study of a global panel of 1236 regions
Zhang, C., Liao, H., Strobl, E., Li, H., Li, R., Jensen, S. S., & Zhang, Y. (2021) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2021.125987 · Cited by 38 · see citing works
Liang, J., Wu, L., Wang, Y., Liang, W., Hao, Y., Tan, M., He, G., Lv, D., Wang, Z., Zeng, T., et al. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133875 · Cited by 40 · see citing works
The COVID-19 vaccine development: A pandemic paradigm
Carneiro, D. D. C., Sousa, J. D. O., & Monteiro-Cunha, J. P. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198454 · Cited by 37 · see citing works
RETRACTED: Why are we vaccinating children against COVID-19?
Kostoff, R. N., Călina, D. C., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P. G., Svistunov, A. А., & Tsatsakis, A. M. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.08.010 · Cited by 38 · see citing works
Retractedde Castro, J. T., de Azevedo, P. O., Fumagalli, M. J., Hojo-Souza, N. S., Salazar, N., Almeida, G. G., Oliveira, L. I., Faustino, L., Antonelli, L. R. D. V., Marçal, T. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32547-y · Cited by 36 · see citing works
Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection
Maity, S., & Saha, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.675419 · Cited by 28 · see citing works
Iguacel, I., Maldonado, A. L., Ruíz-Cabello, A. L., Samatán, E., Alarcón, J., Orte, M. Á., Mateos, S. S., & Martínez‐Jarreta, B. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.739003 · Cited by 33 · see citing works
Porru, S., Spiteri, G., Monaco, M. G. L., Valotti, A., Carta, A., Lotti, V., Diani, E., Lippi, G., Gibellini, D., & Verlato, G. (2022) · Vaccines · doi:10.3390/vaccines10020272 · Cited by 33 · see citing works
Lanini, S., Capone, S., Antinori, A., Milleri, S., Nicastri, E., Camerini, R., Agrati, C., Castilletti, C., Mori, F., Sacchi, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj1996 · Cited by 34 · see citing works
Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges
Hassan, J., Haigh, C., Ahmed, T., Uddin, M. J., & Das, D. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051066 · Cited by 34 · see citing works
- Authors
- Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Hodgson, Susanne H
- ORCID
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 21
- Issue
- 2
- Pages
- e26-e35
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC7837315
- OpenAlex
- W3088489318
- Cited by
- 633
- References
- 79
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 52 · 2023: 99 · 2022: 221 · 2021: 221 · 2020: 14
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- UK Research and Innovation (MC_PC_19055)
- Coalition for Epidemic Preparedness Innovations
- National Institute for Health Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- COVID-19 vaccines, SARS-CoV-2, vaccine efficacy, efficacy endpoints, vaccine development
- MeSH terms
- Immunogenicity, Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Clinical Trials as Topic, Humans, Research Design, Vaccination, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
